Immune Design Corp. (IMDZ)

5.85 +0.01 (+0.171%)

IEX Real-Time Price

March 22, 2019 EST.

NASDAQ Global Market : Healthcare

Prev Close 5.84

Price Open 5.83

Volume: 305,400

Avg Volume: 1.84M

Market Cap: 282.94M

P/E Ratio -5.09

52 Wk Range 1.1-5.85



IMDZ Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-10-15
47.71M
667,850
1.98
1.40%

2018-09-28
47.71M
672,371
3.34
1.41%

2018-09-14
47.71M
709,892
2.35
1.49%

2018-08-31
47.71M
809,373
2.67
1.70%




IMDZ Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-11-06
Q3 2018
AMC
-0.32 (5)
-0.29
0.03

2018-08-01
Q2 2018
N/A
-0.30 (4)
-0.29
0.01

2018-05-03
Q1 2018
N/A
-0.29 (4)
-0.28
0.01

2018-05-02
Q1 2018
AMC
-0.29 (4)
-0.28
0.01

News

INVESTOR ALERT: Monteverde & Associates PC is Investigating the Recently Announced Acquisition (2019-02-26 18:09 PR Newswire)

NEW YORK , Feb. 26, 2019 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City , is investigating: CAS Medical Systems, Inc. (NasdaqGS…

 

Merger Arbitrage Analysis And Spread Performance - February 24, 2019 (2019-02-25 11:26 SeekingAlpha)

This article explains the reasons behind the movement in a selection of the largest U.S. cash merger arbitrage spreads from the past week as calculated by Merger Arbitrage Limited. We analyze the attractiveness and profitability of each spread going forward and indicate the trading position …

 


Statistics

Shares Outstanding: 48.37M

Top 15 Institution Percent: 59.80

Price To Sales: 128.62

Price To Book: 3.08

Revenue: N/A

Gross Profit: N/A

Cash: N/A

Debt: N/A

Return On Assets: -42.98

Return On Equity: -47.37

Profit Margin: N/A

Price History

Beta: 3.46

50-day Moving Avg: 3.39

200-day Moving Avg: 3.05

YTD Change: N/A

5-day Change: 0.17

1-month Change: 0.52

3-month Change: N/A

6-month Change: 72.06

1-year Change: 64.79

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Immune Design Corp.

Exchange: NASDAQ Global Market

Industry: Biotechnology

Sector: Healthcare

Website: http://www.immunedesign.com

Immune Design Corp is a clinical-stage immunotherapy company with next-generation in vivo approaches designed to enable the body's immune system to fight disease.